Embecta Corp. (EMBC)
5.12
-0.43
(-7.75%)
USD |
NASDAQ |
Sep 09, 15:06
Embecta EPS Diluted (Quarterly) : 0.3606 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3606 |
| March 31, 2026 | -0.0691 |
| December 31, 2025 | 0.7438 |
| September 30, 2025 | 0.4485 |
| June 30, 2025 | 0.7778 |
| March 31, 2025 | 0.4014 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.2512 |
| June 30, 2024 | 0.2541 |
| March 31, 2024 | 0.4999 |
| December 31, 2023 | 0.3488 |
| Date | Value |
|---|---|
| September 30, 2023 | 0.1044 |
| June 30, 2023 | 0.264 |
| March 31, 2023 | 0.2434 |
| December 31, 2022 | 0.6152 |
| September 30, 2022 | -0.3015 |
| June 30, 2022 | 1.080 |
| March 31, 2022 | 1.377 |
| December 31, 2021 | 1.739 |
| September 30, 2021 | 1.709 |
| June 30, 2021 | 1.812 |
| March 31, 2021 | 1.867 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Artivion, Inc. | -0.278 |
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.2735 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 21.10M |
| Revenue (Quarterly) | 271.70M |
| Total Expenses (Quarterly) | 250.60M |
| Enterprise Value | 1.598B |
| Gross Profit Margin (Quarterly) | 55.47% |
| Profit Margin (Quarterly) | 7.77% |
| Earnings Yield | 28.98% |
| Operating Earnings Yield | 88.96% |
| Normalized Earnings Yield | 41.79 |